Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trial

Thomas Powles(Queen Mary University of London), Scott T. Tagawa(Cornell University), Christof Vulsteke(AZ Maria Middelares), Marine Gross‐Goupil(Hôpital Saint-André), Se Hoon Park(Samsung Medical Center), Andrea Necchi(Vita-Salute San Raffaele University), M. De Santis(Medical University of Vienna), Ignacio Durán(Instituto de Investigación Marqués de Valdecilla), R. Morales-Barrera(Hebron University), Jun Guo(Peking University), C.N. Sternberg(Cornell University), Joaquim Bellmunt(Harvard University), Peter J. Goebell(Universitätsklinikum Erlangen), M. S. Kovalenko(Gilead Sciences (United States)), Francis Boateng(Gilead Sciences (United States)), M. Sierecki(Gilead Sciences (United States)), Liting Wang(Gilead Sciences (United States)), Camelia S. Sima(Gilead Sciences (United States)), Jana Waldes(Gilead Sciences (United States)), Yohann Loriot(Université Paris-Saclay), Petros Grivas(Fred Hutch Cancer Center)
Annals of Oncology
February 10, 2025
Cited by 70

Abstract


Related Papers

No related papers found

Powered by citation graph analysis